Thermosensitive Polymer-Modified Mesoporous Silica for pH and Temperature-Responsive Drug Delivery

A mesoporous silica-based drug delivery system (MS@PNIPAm-PAAm NPs) was synthesized by conjugating the PNIPAm-PAAm copolymer onto the mesoporous silica (MS) surface as a gatekeeper that responds to temperature and pH changes. The drug delivery studies are carried out in vitro at different pH (7.4, 6.5, and 5.0) and temperatures (such as 25 degrees C and 42 degrees C, respectively). The surface conjugated copolymer (PNIPAm-PAAm) acts as a gatekeeper below the lower critical solution temperature (LCST) (<32 degrees C) and as a collapsed globule structure above LCST (>32 degrees C), resulting in controlled drug delivery from the MS@PNIPAm-PAAm system. Furthermore, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cellular internalization results support the prepared MS@PNIPAm-PAAm NPs being biocompatible and readily taken up by MDA-MB-231 cells. The prepared MS@PNIPAm-PAAm NPs, with their pH-responsive drug release behavior and good biocompatibility, could be used as a drug delivery vehicle where sustained drug release at higher temperatures is required.

Automated summary

A mesoporous silica-based drug delivery system was synthesized by conjugating a PNIPAm-PAAm copolymer onto the mesoporous silica surface. The copolymer acts as a gatekeeper that responds to temperature and pH changes, allowing controlled drug delivery. The system exhibited good biocompatibility and was readily taken up by MDA-MB-231 cells, making it suitable for drug delivery applications where sustained drug release at higher temperatures is required.